CreatorsPublishersAdvertisers
View more in
Cancer

Dr. Marshall on Considerations for Third-Line Therapeutic Options in CRC

onclive.com
 2021-09-14

John L. Marshall, MD, discusses factors to consider in the third-line treatment setting for patients with colorectal cancer. John L. Marshall, MD, chief of the Division of Hematology/Oncology and a professor of Medicine and Oncology at Lombardi Comprehensive Cancer Center, as well as the director of the Otto J. Ruesch Center

www.onclive.com

Comments / 0

Comments / 0